Ukraine plans to reach 5.65 million vaccinations against coronavirus (COVID-19) every month from 2.66 million in April in order to cover the majority of the adult population with vaccinations by the end of 2021 to form herd immunity.
This is provided for by the 2021 National COVID-19 Preventive Vaccination Plan, which the government approved on April 12 by order No. 340 and announced on April 21.
In total, the plan provides for the use of more than 21.913 million doses of vaccines, namely, 8.94 million doses of Oxford/AstraZeneca vaccine, some 10 million doses of the U.S. Novavax, more than 1.91 million doses of the Chinese Sinovac Biotech and 1.07 million doses of Pfizer/BioNTech. Of these, 8 million doses under the COVAX initiative, more than 13.913 million doses purchased from the national budget (10 million of the U.S. Novavax vaccine, some 2 million of Oxford/AstraZeneca, some 1.913 million from the Chinese Sinovac Biotech).
Novavax vaccine deliveries are planned from August, 2 million doses per month. There is no data on the delivery of 10 million doses of Pfizer/BioNTech in the plan (earlier, the press service of the President of Ukraine Volodymyr Zelensky reported on the conclusion of a relevant agreement with the company).
